Before becoming LegalReader's Editor-in-Chief, Jay W. Belle Isle worked as a freelance copywriter with clients on four continents. Jay has a degree in Business Administration from Cleary University and a Juris Doctor from Thomas M. Cooley Law School. Jay has also worked as a contracts administrator for a DOD contractor specializing in vehicle armor.
The Essure Problems website recently published an article titled The Waiting Game. The message is so good that I’m reprinting the article here. I have added new information, where available, in bolded brackets. The Essure Waiting Game article begins below.
Rep. Mike Fitzpatrick (R-PA) just launched the “Faces of E-Free series, focused on sharing the stories of those harmed by Bayer’s “permanent” birth control device, Essure. This ongoing series highlights the dangers of and damages caused by this defective product. Rep. Fitzpatrick is the author of the bipartisan E-Free Act [H.R. 3920].
As bad an idea as that may seem, some drivers are choosing driving with no airbags over risking an explosion of defective Takata airbags. Millions of drivers are waiting for recall replacements but, for the majority, there’s no end in sight. One man took matters into his own hands, literally, and removed the Takata airbags from his vehicle.
Today’s video is a double-edged sword. One edge of that blade, sadly, cuts through women’s flesh. However, the other edge cuts through the lies Bayer and the FDA are telling about the “permanent” birth control product, Essure. I’ll save the best for last, but the preview is that this physician recognized patient’s allergy to Essure.
Dr. Bill Maniatis explains the difference between vasectomy, tubal ligation and Essure in this short video. Honestly guys, it’s short because this is a pretty simple comparison. Don’t hand me some load of crap about your “manhood.” I have the same equipment dangling away down there and my self-worth is not tied up in my sperm count. “But it’s a shot! In the balls! Dude, are you nuts?!” (pun intended)
In a move that frankly gives me pause to wonder if there could actually be a drug company with a heart, Imprimis Pharmaceuticals in San Diego recently announced its intent to sell its version of Daraprim. The price? One dollar per pill for everyone.
Frederick Barnard once said, “A picture is worth one thousand words.” In my life, I’ve often found that to be true. The most recent experience of this has been in watching YouTube videos posted by brave E-Sisters.
This video is just over one year old. It’s a newscast in which the reporter shares information obtained in her investigation of Bayer’s Essure. However, that is not the investigation referred to in this post’s title. The Essure investigation uncovered is actually an FDA investigation of Essure’s original manufacturer, Conceptus. Bayer purchased Essure from Conceptus for $1.1B.
This video is a perfect example of what over 24,000 women are experiencing because of Bayer’s “permanent” birth control device, Essure. I understand many women have had success with this product however, it is naive of Bayer and the FDA to chalk up these adverse reactions to something else. The only common denominator is Essure. Warning: there are graphic images in this video. But, you know what, this is Essure reality.
The FDA announced that it expects to release new guidance regarding the Essure “permanent” birth control device by the end of February 2016. The agency wants to conduct an evidence-based analysis of Bayer’s product before making its recommendations. We live in hope that the evidence is not just more garbage provided by Bayer.